When assessing inventive step for pharmaceutical formulations, courts may consider whether the formulation would have some meaningful therapeutic effect even where the claims do not expressly require a particular level of efficacy, because a pharmaceutical composition must be useful to satisfy the Cripps question.
The full text is available to signed-in members, including the 10 later cases that cite this judgment.